Catalyst Biosciences, Inc.
CBIO
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company whose business model is predicated on animal testing. The company develops and seeks to commercialize novel protease medicines, a process that requires extensive preclinical research involving animal models to assess drug efficacy and safety prior to human trials. This reliance on animal experimentation is central to its product development pipeline.
The company’s public statements acknowledge this activity, noting a commitment to the “ethical care and use of animals in research” and that “animal welfare is always a priority.” However, these assurances describe a standard industry practice for animal testing, not an alternative to it. The core business of developing biologic drugs necessitates the commercial exploitation of animals in research, placing it under this exclusion category.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.